Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...